TY - JOUR
T1 - Proliferating human cells hypomorphic for origin recognition complex 2 and pre-replicative complex formation have a defect in p53 activation and Cdk2 kinase activation
AU - Teer, Jamie K.
AU - Machida, Yuichi J.
AU - Labit, Helene
AU - Novac, Olivia
AU - Hyrien, Olivier
AU - Marheineke, Kathrin
AU - Zannis-Hadjopoulos, Maria
AU - Dutta, Anindya
PY - 2006/3/10
Y1 - 2006/3/10
N2 - The Origin Recognition Complex (ORC) is a critical component of replication initiation. We have previously reported generation of an Orc2 hypomorph cell line (Δ/-) that expresses very low levels of Orc2 but is viable. We have shown here that Chk2 is phosphorylated, suggesting that DNA damage checkpoint pathways are activated. p53 was inactivated during the derivation of the Orc2 hypomorphic cell lines, accounting for their survival despite active Chk2. These cells also show a defect in the G1 to S-phase transition. Cdk2 kinase activation in G1 is decreased due to decreased Cyclin E levels, preventing progression into S-phase. Molecular combing of bromodeoxyuridine-labeled DNA revealed that once the Orc2 hypomorphic cells enter S-phase, fork density and fork progression are approximately comparable with wild type cells. Therefore, the low level of Orc2 hinders normal cell cycle progression by delaying the activation of G1 cyclin-dependent kinases. The results suggest that hypomorphic mutations in initiation factor genes may be particularly deleterious in cancers with mutant p53 or increased activity of Cyclin E/Cdk2.
AB - The Origin Recognition Complex (ORC) is a critical component of replication initiation. We have previously reported generation of an Orc2 hypomorph cell line (Δ/-) that expresses very low levels of Orc2 but is viable. We have shown here that Chk2 is phosphorylated, suggesting that DNA damage checkpoint pathways are activated. p53 was inactivated during the derivation of the Orc2 hypomorphic cell lines, accounting for their survival despite active Chk2. These cells also show a defect in the G1 to S-phase transition. Cdk2 kinase activation in G1 is decreased due to decreased Cyclin E levels, preventing progression into S-phase. Molecular combing of bromodeoxyuridine-labeled DNA revealed that once the Orc2 hypomorphic cells enter S-phase, fork density and fork progression are approximately comparable with wild type cells. Therefore, the low level of Orc2 hinders normal cell cycle progression by delaying the activation of G1 cyclin-dependent kinases. The results suggest that hypomorphic mutations in initiation factor genes may be particularly deleterious in cancers with mutant p53 or increased activity of Cyclin E/Cdk2.
UR - http://www.scopus.com/inward/record.url?scp=33646588731&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33646588731&partnerID=8YFLogxK
U2 - 10.1074/jbc.M507150200
DO - 10.1074/jbc.M507150200
M3 - Article
C2 - 16407251
AN - SCOPUS:33646588731
SN - 0021-9258
VL - 281
SP - 6253
EP - 6260
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 10
ER -